| Primary |
| Muscle Spasticity |
31.2% |
| Product Used For Unknown Indication |
24.1% |
| Drug Use For Unknown Indication |
10.5% |
| Pain |
8.2% |
| Muscle Spasms |
4.4% |
| Multiple Sclerosis |
3.2% |
| Cerebral Palsy |
2.9% |
| Back Pain |
2.4% |
| Overdose |
1.8% |
| Spinal Cord Injury |
1.4% |
| Alcoholism |
1.3% |
| Suicide Attempt |
1.3% |
| Depression |
1.1% |
| Dystonia |
1.0% |
| Post Laminectomy Syndrome |
1.0% |
| Hiccups |
0.9% |
| Muscle Relaxant Therapy |
0.9% |
| Cancer Pain |
0.8% |
| Cerebrovascular Accident |
0.8% |
| Intentional Overdose |
0.8% |
|
| Death |
11.0% |
| Overdose |
9.1% |
| Vomiting |
7.4% |
| Somnolence |
6.3% |
| Withdrawal Syndrome |
6.3% |
| Urinary Tract Infection |
5.7% |
| Neurotoxicity |
5.3% |
| Toxicity To Various Agents |
5.3% |
| Poisoning |
5.0% |
| Muscle Spasticity |
4.6% |
| Pneumonia |
4.6% |
| Unresponsive To Stimuli |
4.3% |
| Pain |
4.0% |
| Implant Site Effusion |
3.5% |
| Respiratory Arrest |
3.2% |
| Drug Withdrawal Syndrome |
2.9% |
| Pyrexia |
2.9% |
| Tachycardia |
2.9% |
| Suicide Attempt |
2.8% |
| Tremor |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
27.6% |
| Drug Use For Unknown Indication |
18.0% |
| Pain |
12.1% |
| Depression |
6.3% |
| Muscle Spasticity |
5.5% |
| Multiple Sclerosis |
3.8% |
| Multiple Drug Overdose |
3.2% |
| Hypertension |
3.2% |
| Muscle Spasms |
2.7% |
| Back Pain |
2.3% |
| Alcoholism |
2.2% |
| Fibromyalgia |
1.9% |
| Anxiety |
1.8% |
| Convulsion |
1.7% |
| Dystonia |
1.6% |
| Suicide Attempt |
1.5% |
| Trigeminal Neuralgia |
1.4% |
| Overdose |
1.1% |
| Diabetes Mellitus |
1.1% |
| Constipation |
1.0% |
|
| Completed Suicide |
17.8% |
| Somnolence |
8.3% |
| Toxicity To Various Agents |
8.2% |
| Respiratory Arrest |
6.7% |
| Vomiting |
6.2% |
| Death |
6.0% |
| Suicide Attempt |
5.4% |
| Fibromyalgia |
4.0% |
| Unresponsive To Stimuli |
4.0% |
| Drug Toxicity |
3.8% |
| Weight Decreased |
3.8% |
| Overdose |
3.6% |
| Ventricular Tachycardia |
3.3% |
| Weight Increased |
3.1% |
| Gastric Ulcer |
2.9% |
| Pain |
2.7% |
| Poisoning |
2.7% |
| Ataxia |
2.5% |
| Disorientation |
2.5% |
| Sinus Bradycardia |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.1% |
| Multiple Sclerosis |
23.1% |
| Drug Use For Unknown Indication |
8.6% |
| Pain |
8.0% |
| Muscle Spasms |
5.4% |
| Depression |
4.8% |
| Muscle Spasticity |
3.8% |
| Hypertension |
3.3% |
| Relapsing-remitting Multiple Sclerosis |
2.3% |
| Anxiety |
2.2% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Back Pain |
1.6% |
| Neuralgia |
1.6% |
| Constipation |
1.4% |
| Asthma |
1.3% |
| Insomnia |
1.3% |
| Osteoporosis |
1.2% |
| Sleep Disorder |
1.2% |
| Fatigue |
1.1% |
| Nausea |
1.1% |
|
| Urinary Tract Infection |
14.0% |
| Vomiting |
11.6% |
| Multiple Sclerosis Relapse |
6.8% |
| Weight Decreased |
6.8% |
| Pain |
5.5% |
| Weight Increased |
4.8% |
| Pneumonia |
4.5% |
| Nausea |
4.5% |
| Somnolence |
4.3% |
| Vision Blurred |
4.2% |
| Pain In Extremity |
4.1% |
| Tremor |
4.0% |
| Multiple Sclerosis |
3.7% |
| White Blood Cell Count Decreased |
3.5% |
| Pyrexia |
3.4% |
| Drug Ineffective |
3.2% |
| Death |
2.9% |
| Convulsion |
2.8% |
| Fatigue |
2.8% |
| Headache |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
19.3% |
| Drug Use For Unknown Indication |
10.2% |
| Muscle Spasms |
9.1% |
| Muscle Relaxant Therapy |
8.0% |
| Alcoholism |
6.8% |
| Back Pain |
6.8% |
| Hypertension |
6.8% |
| Bipolar Disorder |
4.5% |
| Major Depression |
3.4% |
| Multiple Sclerosis |
3.4% |
| Affective Disorder |
2.3% |
| Cardiac Failure |
2.3% |
| Cerebrovascular Accident |
2.3% |
| Epilepsy |
2.3% |
| Fibromyalgia |
2.3% |
| Insomnia |
2.3% |
| Neuropathy |
2.3% |
| Psychotic Disorder |
2.3% |
| Viral Infection |
2.3% |
| Anxiety Disorder |
1.1% |
|
| Drug Interaction |
13.3% |
| Pyrexia |
10.0% |
| Somnolence |
10.0% |
| Vomiting |
10.0% |
| Road Traffic Accident |
6.7% |
| Sopor |
6.7% |
| Tremor |
6.7% |
| Weight Increased |
6.7% |
| Erythema |
3.3% |
| Hypotension |
3.3% |
| Incoherent |
3.3% |
| Loss Of Consciousness |
3.3% |
| Malaise |
3.3% |
| Muscle Spasticity |
3.3% |
| Nausea |
3.3% |
| Respiratory Distress |
3.3% |
| Vulvovaginal Dryness |
3.3% |
|
